Cigna To Exit Obamacare In 2027 Amid Rising Costs

Authored by Mary Prenon via The Epoch Times,

The Cigna Group, one of the country’s largest health services and insurance firms, is joining others, including Aetna and UnitedHealthcare, in divesting its individual health exchange business.

By the end of 2026, Cigna Group will no longer offer insurance through the Affordable Care Act (ACA), also known as “Obamacare,” the company said during its April 30 earnings call.

According to its first-quarter earnings report, as of March 31, the company’s individual exchange business had 369,000 members in individual and family plans.

“We did not make this decision lightly, and appreciate the importance of ensuring patients have continuity through the transition,” Brian Evanko, Cigna Group’s president, chief operating officer, and incoming CEO, said during the earnings call.

“Looking to the future, there’s no question that the status quo in healthcare is unsustainable. Costs continue to rise, as does demand for healthcare services, an untenable equation,” he said.

“We will support members through their open enrollment transitions into 2027.”

Cigna’s decision comes after other health insurance companies, such as CVS Health and UnitedHealthcare, divested insurance business under the ACA.

In its first-quarter 2025 earnings report, released on Feb. 10, CVS Health announced that it was exiting its individual exchange business, where its health insurance arm, Aetna, independently operates ACA plans, beginning in 2026.

Years earlier, UnitedHealthcare said in a filing to the Securities and Exchange Commission in December 2016 that its Employer and Individual program would participate in individual public exchanges in only three states in 2017, a sharp reduction from 34 states in 2016.

At the beginning of this year, the Alliance of Safety-net Hospitals predicted that expiring tax credits for buying health insurance under ACA exchanges could affect nearly 4.8 million people in 2026, as the cost of such plans continues to escalate.

Evanko said Cigna’s decision to vacate the individual healthcare business now is necessary in order to support the firm’s strategic direction for the future. This will allow the insurer to focus its efforts on enhancing customer service with streamlined pharmacy services and additional system improvements.

Evanko noted that over the years, Cigna has continued to add or subtract from its portfolio as needed to position its core healthcare business for sustainable growth.

Last year, Cigna divested its group life and disability business, touting the recent sale of its Medicare businesses.

“Divesting each of these assets enabled greater focus and investment in the remaining businesses within our portfolio, supporting our forward-looking growth path,” he noted.

However, in 2025, Cigna acquired CarepathRx, a pharmacy service dealing with more than 40 health systems and 1,000 hospitals. Last year, Cigna also invested in Shields Health Solutions, which allows it to partner with hospitals and health systems serving patients with complex needs or requiring specialty medications.

Cigna’s first-quarter earnings of $68.52 billion outpaced market expectations of $66.2 billion. Its earnings per share of $7.79 also exceeded the forecasted $7.61.

However, the company’s shares declined by 2.64 percent on May 1, closing at $282.90.

Going forward, Evanko said the insurer plans to continue embracing data and modern technology to improve customer satisfaction and offer more personalized services.

Evanko noted that Cigna has also introduced Signature, its new rebate-free pharmacy benefits model.

According to Evanko, high-cost branded prescriptions represent about 10 percent of all prescriptions nationwide, but nearly 90 percent of total drug spending. The new Signature model is designed with the patient at the center, and its Price Assure capacity guarantees consumers the lowest possible out-of-pocket costs when filling their prescriptions.

Cigna expects the Signature model to become standard in 2028 and for at least 50 percent of its Evernorth Pharmacy Benefit Services members to be enrolled in Signature by the end of 2028.